‘Investigation of poly-arginine peptide neuroprotective mechanisms using an in vitro neurotrauma injury model’. Meloni B, Knuckey N, Chiu L, Anderton R. $100,000. Neurotrauma Research Program.
‘Pre-clinical assessment of poly-arginine R18 peptide as neuroprotective agent for perinatal hypoxic-ischaemic encephalopathy (HIE)’. Meloni B. Telethon –Perth Children’s Hospital Research Fund 2017 (Round 6). $125,000.
Pre-clinical assessment of poly-arginine peptide R18D as a therapeutic to reduce central nervous system injury following neurotrauma. Meloni, Knuckey, Hodgetts, Cross. 2017: $99,650. Neurotrauma Research Program of WA.